CD8A and neoplasm: Gaudreau et al. found that neoadjuvant chemotherapy is associated with increased infiltration of cytotoxic CD8+ T cells and CD20+ B cells, promoting anti-tumor immunity through changes in the phenotype of cytotoxic and memory CD8+ and CD4+ T cells [14].